Owing to its importance in cancer progression, aberrant c-Met signalling has been studied specifically in the context of HNSCC mainly by identifying MET gene mutations and copy number alterations or by assessing c-Met overexpression8. Here, MET is linked to head and neck squamous cell carcinoma.